Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Renalytix Reports Financial Results for Q3 FY2024

May 15, 2024
RNS Number : 5079O Renalytix PLC 15 May 2024   Renalytix plc ("Renalytix" or the "Company")   Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024   LONDON and NEW YORK , May 15, 2024   - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro

Holding(s) in Company

May 14, 2024
RNS Number : 3993O Renalytix PLC 14 May 2024   TR-1: Standard form for notification of major holdings Delayed announcement due to change in the holding as a results of placing as announced on the 12 March 2024 1. Issuer Details ISIN GB00BYWL4Y04 Issuer Name RENALYTIX PLC UK or Non- UK Issuer UK 2.

Holding(s) in Company

May 14, 2024
RNS Number : 3991O Renalytix PLC 14 May 2024   TR-1: Standard form for notification of major holdings Delayed announcement 1. Issuer Details ISIN GB00BYWL4Y04 Issuer Name RENALYTIX PLC UK or Non- UK Issuer UK 2. Reason for Notification An event changing the breakdown of voting rights 3.

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

May 14, 2024
RNS Number : 3323O Stifel Nicolaus Europe Limited 14 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Notice of Q3 Results

May 9, 2024
RNS Number : 6885N Renalytix PLC 09 May 2024     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15   LONDON and SALT LAKE CITY , May 9, 2024 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that it will report its

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

May 7, 2024
RNS Number : 4046N Stifel Nicolaus Europe Limited 07 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

May 3, 2024
RNS Number : 1670N Stifel Nicolaus Europe Limited 03 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

May 2, 2024
RNS Number : 9970M Stifel Nicolaus Europe Limited 02 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Holding(s) in Company

May 1, 2024
RNS Number : 8938M Renalytix PLC 01 May 2024   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS   (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares

Form 8.3 - Renalytix plc

May 1, 2024
RNS Number : 8811M NR Holdings Limited 01 May 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: NR
Displaying 11 - 20 of 393